These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 21446844)

  • 1. Homology modeling and binding site assessment of the human P-glycoprotein.
    Tarcsay A; Keseru GM
    Future Med Chem; 2011 Mar; 3(3):297-307. PubMed ID: 21446844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do drug substrates enter the common drug-binding pocket of P-glycoprotein through "gates"?
    Loo TW; Clarke DM
    Biochem Biophys Res Commun; 2005 Apr; 329(2):419-22. PubMed ID: 15737603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the inward- and outward-open homology models and ligand binding of human P-glycoprotein.
    Pajeva IK; Globisch C; Wiese M
    FEBS J; 2009 Dec; 276(23):7016-26. PubMed ID: 19878299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational models for predicting substrates or inhibitors of P-glycoprotein.
    Chen L; Li Y; Yu H; Zhang L; Hou T
    Drug Discov Today; 2012 Apr; 17(7-8):343-51. PubMed ID: 22119877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The flexibility of P-glycoprotein for its poly-specific drug binding from molecular dynamics simulations.
    Liu M; Hou T; Feng Z; Li Y
    J Biomol Struct Dyn; 2013; 31(6):612-29. PubMed ID: 22888853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidrug resistance P-glycoprotein: crucial significance in drug disposition and interaction.
    Sun J; He ZG; Cheng G; Wang SJ; Hao XH; Zou MJ
    Med Sci Monit; 2004 Jan; 10(1):RA5-14. PubMed ID: 14704647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular docking characterizes substrate-binding sites and efflux modulation mechanisms within P-glycoprotein.
    Ferreira RJ; Ferreira MJ; dos Santos DJ
    J Chem Inf Model; 2013 Jul; 53(7):1747-60. PubMed ID: 23802684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleotide binding to the multidrug resistance P-glycoprotein as studied by ESR spectroscopy.
    Delannoy S; Urbatsch IL; Tombline G; Senior AE; Vogel PD
    Biochemistry; 2005 Oct; 44(42):14010-9. PubMed ID: 16229490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transmembrane segment 7 of human P-glycoprotein forms part of the drug-binding pocket.
    Loo TW; Bartlett MC; Clarke DM
    Biochem J; 2006 Oct; 399(2):351-9. PubMed ID: 16813563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional assessment of multiple P-glycoprotein (P-gp) probe substrates: influence of cell line and modulator concentration on P-gp activity.
    Taub ME; Podila L; Ely D; Almeida I
    Drug Metab Dispos; 2005 Nov; 33(11):1679-87. PubMed ID: 16093365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of P-glycoprotein substrates by a support vector machine approach.
    Xue Y; Yap CW; Sun LZ; Cao ZW; Wang JF; Chen YZ
    J Chem Inf Comput Sci; 2004; 44(4):1497-505. PubMed ID: 15272858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P-glycoprotein: from genomics to mechanism.
    Ambudkar SV; Kimchi-Sarfaty C; Sauna ZE; Gottesman MM
    Oncogene; 2003 Oct; 22(47):7468-85. PubMed ID: 14576852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico exploration of phenytoin binding site in two catalytic states of human P-glycoprotein models.
    Cleave SS; Panda R; Suresh PK
    Indian J Biochem Biophys; 2013 Feb; 50(1):7-13. PubMed ID: 23617068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of highly functionalized barbituric acids and study of their interactions with p-glycoprotein and Mg2+--potential candidates for multi drug resistance modulation.
    Singh P; Kaur J; Bhardwaj A
    Eur J Med Chem; 2010 Mar; 45(3):1256-62. PubMed ID: 20053485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The permeability P-glycoprotein: a focus on enantioselectivity and brain distribution.
    Choong E; Dobrinas M; Carrupt PA; Eap CB
    Expert Opin Drug Metab Toxicol; 2010 Aug; 6(8):953-65. PubMed ID: 20504109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter.
    Lee CG; Gottesman MM; Cardarelli CO; Ramachandra M; Jeang KT; Ambudkar SV; Pastan I; Dey S
    Biochemistry; 1998 Mar; 37(11):3594-601. PubMed ID: 9530286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P-glycoprotein related drug interactions: clinical importance and a consideration of disease states.
    Lee CA; Cook JA; Reyner EL; Smith DA
    Expert Opin Drug Metab Toxicol; 2010 May; 6(5):603-19. PubMed ID: 20397967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The drug-binding pocket of the human multidrug resistance P-glycoprotein is accessible to the aqueous medium.
    Loo TW; Bartlett MC; Clarke DM
    Biochemistry; 2004 Sep; 43(38):12081-9. PubMed ID: 15379547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting the three-dimensional structure of human P-glycoprotein in absence of ATP by computational techniques embodying crosslinking data: insight into the mechanism of ligand migration and binding sites.
    Vandevuer S; Van Bambeke F; Tulkens PM; Prévost M
    Proteins; 2006 May; 63(3):466-78. PubMed ID: 16463278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of putative binding sites of P-glycoprotein based on its homology model.
    Globisch C; Pajeva IK; Wiese M
    ChemMedChem; 2008 Feb; 3(2):280-95. PubMed ID: 18175303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.